Clinical Trials Logo

Dissociative Disorders clinical trials

View clinical trials related to Dissociative Disorders.

Filter by:

NCT ID: NCT03902795 Completed - Retinal Detachment Clinical Trials

Functional and Morphological Results of Rhegmatogenous Retinal Detachment Treated With Vitrectomy

Start date: March 2016
Phase:
Study type: Observational

To examine morphological and functional results after pars plana vitrectomy (PPV) with SF6 gas tamponade due to macula-on and macula-off rhegmatogenous retinal detachment (RRD) during six months of the follow-up.

NCT ID: NCT03780972 Completed - Clinical trials for Rhegmatogenous Retinal Detachment - Macula Off

A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment

Start date: October 21, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of ONL1204 in participants with Macula-off, Rhegmatogenous Retinal Detachment (RRD). RRD is an acute and serious vision threatening condition in which a tear in the retina, typically resulting from a vitreous detachment, allows liquid to accumulate under the retina, detaching the photoreceptor (PR) layer of the retina from the retinal pigment epithelium (RPE). As the RPE is the principal source of nutritional support for the PR layer, the photoreceptors begin a cascade of inflammation and cell death. Photoreceptor cell death is the primary mechanism of vision loss after retinal detachment. ONL1204 is a first-in-class inhibitor of Fragment Apoptosis Stimulator receptor (Fas)-mediated cell death. ONL1204 has demonstrated protection of multiple retinal cell types in numerous preclinical models of acute ocular injury. This will be a first-in-human (FIH) study to evaluate safety and tolerability of a single-dose of ONL1204 in participants with macula-off RRD. The standard of care for surgical repair of macula-off RRD is reattachment surgery within 7 days of the macula detaching. Participants in this study will receive a single intravitreal injection upon diagnosis and enrollment in the study, followed by standard of care surgery. The surgery includes vitrectomy, a procedure that removes the bulk of drug remaining in the vitreous.

NCT ID: NCT03714503 Recruiting - Clinical trials for Retina; Detachment, Rhegmatogenous

Head Positioning After Retina Detachment Repair

Start date: April 8, 2019
Phase: N/A
Study type: Interventional

This study aims to determine if one day post-operative prone head positioning can be as good as seven days post-operative prone head positioning in patients with retinal detachments with inferior retinal breaks after pars that pars plana vitrectomy (PPV) using perfluoropropane (C3F8) gas as a tamponade. The investigator will conduct a single arm phase II study using a Simon's two-stage design

NCT ID: NCT03707015 Completed - Surgery Clinical Trials

Internal Limiting Membrane Flap in the Management of Retinal Detachment Due to Paracentral Retinal Breaks

Start date: January 2017
Phase:
Study type: Observational

To describe the technique and outcomes of using either inverted or free internal limiting membrane flap in the management of retinal detachment due to paracentral retinal breaks.

NCT ID: NCT03655652 Recruiting - Retinal Detachment Clinical Trials

Preoperative Progression of Retinal Detachment

Start date: February 1, 2018
Phase:
Study type: Observational

Patients are required to position prior to retinal detachment surgery. We seek to see whether there is a correlation between the performed positioning and retinal detachment progression/regression in fovea-on retinal detachment patients.

NCT ID: NCT03618498 Completed - Retinal Detachment Clinical Trials

Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment

ILMFCMHRDPDR
Start date: March 7, 2018
Phase: N/A
Study type: Interventional

Purpose: To evaluate the logical surgical approaches in closing macular holes in eyes of proliferative diabetic retinopathy with retinal detachment

NCT ID: NCT03542162 Completed - Clinical trials for Rhegmatogenous Retinal Detachment

Healaflow Patch for the Treatment of Rhegmatogenous Retinal Detachment

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

To report the surgical results of primary rhegmatogenous retinal detachment (RRD) repaired by 27G pars plana vitrectomy (PPV) combined with Healaflow patch and air tamponade, and do not need prone position postoperation.

NCT ID: NCT03515239 Not yet recruiting - Clinical trials for Lumbosacral Instability

Comparative Study Between Unillateral and Bilateral Lumbopelvic Fixation for Spinopelvic Dissociation

Start date: June 1, 2019
Phase:
Study type: Observational

Lumbopelvic fixation is the treatment opation for spinopelvic dissociation. In our study we will compare unilateral versus bilateral lumbopelvic fixation as regarding functional outcomes by Majeed score along a period of 12vmonths as a primary measure and metal failure,skin condition and nonunion as secondaries.

NCT ID: NCT03441867 Active, not recruiting - Epilepsy Clinical Trials

Neuroimaging Biomarker for Seizures

NIBMSZS
Start date: September 15, 2017
Phase: N/A
Study type: Interventional

This multi-site study will examine patients with epilepsy (ES) following head injury [i.e., posttraumatic epilepsy (PTE)] and posttraumatic psychogenic Non-epileptic seizures (PNES) and will compare them to patients with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.

NCT ID: NCT03433547 Completed - Macular Holes Clinical Trials

Effects of Macular Buckle Versus Vitrectomy on Macular Hole and Macular Detachment in Highly Myopic Eyes

Start date: January 30, 2018
Phase: N/A
Study type: Interventional

Full-thickness macular Hole associated with macular detachment is a one of the maculopathies of high myopia. There is controversy in the primary treatment for this situation. This study will compare the effects of macular buckling versus vitrectomy in a cohort of highly myopic eyes with this situation.